Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 1,986.90
-34.90 (-1.73%)
Sep 17, 2025, 3:30 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 327.35 billion as of September 17, 2025. Its market cap has increased by 8.07% in one year.
Market Cap
327.35B
Enterprise Value
300.97B
Revenue
57.20B
Ranking
n/a
PE Ratio
42.50
Stock Price
1,986.90
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 327.35B, an increase of 10.18%. That is a compound annual growth rate of 2.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 327.35B | 11.67% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | 382.04B | 28.59% |
| Nov 20, 2020 | 297.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,843.73B |
| Divi's Laboratories | 1,607.94B |
| Cipla | 1,259.29B |
| Apollo Hospitals Enterprise | 1,123.89B |
| Mankind Pharma | 1,067.15B |
| Zydus Lifesciences | 1,043.36B |
| Fortis Healthcare | 729.78B |
| Alkem Laboratories | 657.97B |